Celebrity Inventors
Actor Marlon Brando has four patents, all named "Drumhead tensioning device and method."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7285574 | Methods for treating neural cell swelling A composition comprising a novel Ca2+-activated, [ATP]i-sensitive nonspecific cation (NCCa-ATP) channel is described. The channel is found in mammalian neural cells and exhibits a different sensitivity to block by various adenine nuc... | 10/23/2007 |
| 7147864 | Methods for preventing photodamaged skin by administering selegiline or desmethylselegiline The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline. | 12/12/2006 |
| 7097860 | Method and composition for treatment of inflammatory and inflammation-related disorders A method of reducing inflammation in a variety of disorders by using an intraperitoneal solution of magnesium. The solution can be used for treating inflammatory and inflammation-related disorders in animals and/or humans. Application of the solution reduces inflamm... | 08/29/2006 |
| 6841551 | Brain, spinal, and nerve injury treatment A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a ... | 01/11/2005 |
| 6828349 | Treatment of addiction and addiction-related behavior The present invention provides a highly efficient method for treating substance addiction and for changing addiction-related behavior of a mammal suffering from substance addiction. The method includes administering to a mammal an effective amount of gamma vinylGABA... | 12/07/2004 |
| 6709664 | Methods for treating photodamaged skin by administering selegiline or desmethylselegiline The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline. | 03/23/2004 |
| 6500809 | Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith Neural tissue edema is treated by circulating a hyperoncotic artificial cerebrospinal fluid in the cerebrospinal fluid pathway in the vicinity of edematous tissue to cause the edematous tissue to be dehydrated due to an oncotic gradient between the hypert... | 12/31/2002 |
| 6462016 | Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method There are provided a method to screen agonist or antagonist of the maxadilan receptor participating in vasodilating action, wherein a receptor of maxadilan is used, compounds which specifically bind to the receptor, and a tissue preparation having the rec... | 10/08/2002 |
| 6258846 | Nutritional supplements The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional... | 07/10/2001 |
| 6238707 | Herbal hormone balance composition The present invention comprises a selection of herbal, organic and inorganic materials with curative effects combined in a powdered form for human ingestion. The demonstrated benefits on human female hormone regulation or replacement include return from i... | 05/29/2001 |
| 6136862 | Cerebral function improving agents A cerebral function improving agent containing as the active ingredient a compound represented by the following formula: ##STR1## wherein R2 represents a hydrogen atom when R1 is a hydroxyl group; or R1 or R1 | 10/24/2000 |
| 5945448 | Brain edema inhibitor The present invention relates to a composition for treating or preventing brain edemas which comprises containing an endothelin antagonist as an active ingredient, for example, the compound of the following formula (I): ##STR1## or pharmaceutically a... | 08/31/1999 |
| 5912018 | Methods for treatment of muscle spasm, edema and dermatological conditions using epidermal gel secretion from an arabian gulf catfish The present invention provides an epidermal gel secretion of Arabian Gulf catfish which is useful in enhancing wound healing, alleviating muscle spasms and pain, and treating dermatological disorders.... | 06/15/1999 |
| 5886053 | Use of carotenoids for producing drugs for the treatment of dermatoses The use of carotenoids for producing drugs for the treatment of inflammatory disorders not caused by the action of light or an infection with microorganisms.... | 03/23/1999 |
| 5776504 | Magnesium taurate for prevention and treatment of pre-eclampsia/eclampsia A magnesium-taurine compound and its method of synthesis. The compound is synthesized by reacting taurine and magnesium in a 2:1 molar ratio. The resulting mixture is diluted with methanol and the remaining clear filtrate is crystallized from methanol. Th... | 07/07/1998 |
| 5646156 | Inhibition of eosinophil activation through A3 adenosine receptor antagonism The invention concerns the identification on eosinophils of the A3 adenosine receptor subtype and the blockade of said receptor in order to achieve inhibition of eosinophil activation and degranulation.... | 07/08/1997 |
| 5530001 | Pharmaceutical use of dihydropyridine derivative A novel pharmaceutical use of a dihydropyridine derivative of the formula (I) ##STR1## wherein R1, R2 and R3 are the same or different and each is an alkyl or the like; R4 is a hydrogen atom or the like; R | 06/25/1996 |
| 5478844 | Method of using aminocoumaran derivatives for treating cerebrovascular diseases A novel aminocoumaran derivatives of the general formula (I): ##STR1## wherein R1 and R2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R3, R4 and R5... | 12/26/1995 |
| 5466667 | Prophylactic and therapeutic methods for treating edema with antamanides Unique methods for treating edemas in living subjects are provided comprising administering an effective amount of an antamanide or an antamanide analogue to the subject. The methods offer prophylactic and therapeutic modes of treatment for both localized... | 11/14/1995 |
| 5409903 | Method and compositions for the treatment of H. pylori and dermatitis A method of treating a mammal for the presence or the activity of H. pylori in the gastrointestinal tract is disclosed. The method encompasses orally administering to said mammal a sufficient amount of a scavenging, reacting or inactivating compound to re... | 04/25/1995 |
| 5278143 | Prophylactic and therapeutic methods for treating interleukin-mediated edemas Unique methods for treating interleukin-mediated edemas in living subjects are provided comprising administering an effective amount of a composition selected from the group consisting of phallotoxins, phallotoxin analogues, antamanide, or an antamanide a... | 01/11/1994 |
| 5188838 | Process for the preparation of medications in the form of pearls Process for the preparation of pearls based on a pharmaceutical active substance exhibiting an indefinite crystallization point. The said active substance is mixed in molten form which a pharmaceutical excipient promoting the solidification of the active ... | 02/23/1993 |
| 5182299 | Treatment of osmotic disturbance with organic osmolytes A method of treating an osmotic disturbance in an animal which comprises administering to an animal an effective amount of an organic osmolyte, wherein the organic osmolyte is a polyol. Specific polyols include myo-inositol and sorbitol. Also included are... | 01/26/1993 |
| 5047429 | Treatment of oedema A method is described for treating and/or preventing pulmonary oedema in patients comprising administering a suphonylurea compound or a pharmaceutically acceptable salt thereof to patients who suffer from or are susceptible to oedema. Glucose may also be ... | 09/10/1991 |
| 5032612 | Non-smoking aid A mouthwash is disclosed and claimed which comprises silver acetate, ammonium nitrate, and nitric acid which, when present as a residue in the oral cavity, will cause an adverse taste when the user smokes a tobacco product. The bitter taste experience cau... | 07/16/1991 |
| 4992469 | Method of obtaining an antiplatelet effect A quinone derivative of the formula (I): ##STR1## in which A is a group of the formula (IV): ##STR2## or a group of the formula (V): ##STR3## in which X and Y are either the same as or different from each other and each are hydroxy, me... | 02/12/1991 |
| 4970301 | 2-(piperazinyl)-2-oxoethylene-substituted flavonoid compounds Compound of general formula I: ##STR1## in which: A is a single or double bond, R1 and R3, which may be identical or different, are each a hydrogen atom, an alkoxycarbonylmethylene radical of formula --CH2 CO2 | 11/13/1990 |
| 4959355 | Method of inhibiting osmotic water flow This invention provides a method of inhibiting osmotic water flow across mammalian cell membranes which involves contacting the water channels of the cell membranes with an effective amount of a glucose transport blocker or of digitonin so as to inhibit o... | 09/25/1990 |
| 4946832 | Cosmetic base composition with therapeutic properties Cosmetic Base composition exhibiting therapeutic properties comprising an acyl fatty acid alpha-hydroxy carboxylic acid ester or alkali metal salt thereof, a sucrose fatty acid ester, and a solvent.... | 08/07/1990 |
| 4851450 | Compounds for inhibition of platelet activating factor activity The present invention is a group of biologically active agents, di-hydroxy alkyl glycerols with vicinal hydroxyl groups and their acetyl-derivatives having the general formula: ##STR1## where R is selected from the group of H and CH3 CO-- ... | 07/25/1989 |
| 4822601 | Cosmetic base composition with therapeutic properties Cosmetic Base composition exhibiting therapeutic properties includes an acyl fatty acid lactylate ester or alkali metal salt thereof, a sucrose fatty acid ester, and a solvent.... | 04/18/1989 |
| 4542026 | Method of treating vasomotor disorders An agent and method for treating vasomotor disorders, particularly migraine and menstrual pain is provided wherein the method comprises administering to said patient, intravenously or orally, an effective dose of the agent according to the invention, Vita... | 09/17/1985 |
| 4510322 | Indacrinone having enhanced uricosuric The uricosuric and diuretic properties of indacrinone, [6,7-dichloro-2,3-dihydro-2-methyl-1-oxo-2-phenyl-1H-inden-5-yl)oxy]acetic acid, are carefully balanced for maximum therapeutic benefit by manipulation of the proportion of (+) and (-) enantiomers in ... | 04/09/1985 |
| 4483867 | Antifibrinolytically active derivatives of tranexamic acid Novel antifibrinolytically active compounds of the formula ##STR1## and therapeutically acceptable salt thereof, wherein R1 is selected from the group consisting of (a) alkyl groups containing 1-4 carbon atoms, (b) alkoxy groups containing 1-4 carbo... | 11/20/1984 |
| 4478843 | 5-Phenyltetrazoles and their use as salidiuretics What are disclosed are salidiuretic compounds of the formula ##STR1## and physiologically acceptable salts thereof, wherein R is phenyl, furyl or thienyl, intermediates of said compounds, methods for making said compounds, salidiuretic pharmaceutical... | 10/23/1984 |
| 4454132 | Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension Novel substituted pyrazinyl-1,2,4-oxadiazoles and processes for preparing the same. The compounds are useful in the treatment of edema and hypertension.... | 06/12/1984 |
| 4443466 | 4-Benzyl- and 4-benzoyl-substituted imidazole derivatives and use as medicaments The invention provides compounds of the formula: ##STR1## wherein R1, R2 and R3, which can be the same or different, are each hydrogen, chloro, bromo, fluoro, methyl, ethyl, methoxy, amino, hydroxy or nitro; R4 | 04/17/1984 |
| 4440770 | Diuretic, hypotensive and antiedemic quinoline oximes A pharmaceutical composition having diuretic, hypotensive and antiedemic effects which contains a 6-halo-4-oximino-1,2,3,4-tetrahydroquinoline derivative or a salt thereof, and a method to use the above-described derivative or a salt thereof as a diuretic... | 04/03/1984 |
| 4435422 | 5-Substituted 2,3-dihydrobenzofuran-2-carboxylic acids and their use in diuretic compositions Described are compounds of the formula ##STR1## wherein R1 and R2 independently of one another denote hydrogen or loweralkyl; A is CO, CH2, O, S, SO or CHOH; X is hydrogen, halo, loweralkyl, or --CH2 NR | 03/06/1984 |
| 4428955 | Benzopyran compounds, pharmaceutical compositions containing them and methods of use The present invention provides benzopyranyl ethers of the general formula: ##STR1## wherein A is an alkylene radical containing 2 to 4 carbon atoms and R is a hydrogen atom or an acyl radical; as well as the salts thereof with pharmacologically accep... | 01/31/1984 |
